Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

FDA approves groundbreaking Alzheimer's drug amid legal turmoil



Black Friday Offer

Get Lifetime Access to Full Government Meeting Transcripts

$99/year $199 LIFETIME

Lifetime access to full videos, transcriptions, searches & alerts • County, city, state & federal

Full Videos
Transcripts
Unlimited Searches
Real-Time Alerts
AI Summaries
Claim Your Spot Now

Limited Spots • 30-day guarantee

This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

FDA approves groundbreaking Alzheimer's drug amid legal turmoil
A heat wave is set to persist into next week, raising concerns about public health and safety as temperatures soar. In a significant development in medical treatment, the FDA has approved Kizumla, a new Alzheimer's drug that has shown promise in modestly slowing the progression of the disease. This marks only the second approval of a drug aimed at treating Alzheimer's, specifically for mild or early cases of dementia.

In legal news, the sentencing for Donald Trump's hush money case has been postponed until at least September 18th, originally scheduled for July 11th. Judge Juan Mershon is weighing the implications of a recent Supreme Court decision that expands presidential immunity. Trump was convicted in May on 34 counts of falsifying business records related to payments made to adult film star Stormy Daniels.

Additionally, a Manhattan appeals court has disbarred former New York City mayor Rudy Giuliani for making false statements regarding election fraud claims. The court found that Giuliani intentionally undermined the integrity of the electoral process, despite his assertion that he was unaware of the falsehoods he propagated.

The Supreme Court, having recently concluded a significant term, announced it will hear several high-profile cases in the fall. These include a challenge to the FDA's ban on flavored e-cigarette marketing and a Texas law mandating age verification for access to pornographic websites. However, the court declined to review a challenge to an Illinois ban on certain semiautomatic weapons and high-capacity magazines, a decision that could have influenced laws in multiple states.

View full meeting

This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.

View full meeting